Don't Play Their Game
Wait, That's Why Dems Are Scared About ICE Agents Wearing Body Cams
Bill Maher Had the Perfect Response to Billie Eilish's 'Stolen Land' Nonsense
Some Guy Wanted to Test Something at an Anti-ICE Rally. Their Reaction Says...
Here's What Trump Had to Say About That Olympic Athlete Who Bashed His...
Check Out How the Media Portrayed Japan's Conservative Party's Big Election Win
Jonathan Turley Wrecks Jamelle Bouie for His Despicable Attack on Vance's Mom
Is Prime Minister Keir Starmer Going to Resign?
Gold Medal Motherhood
TMZ's Halftime Show Poll Isn't Going the Way They Hoped
Bakari Sellers Says America Needs a 'Fumigation' of MAGA
Don Lemon Plays Civil Rights Martyr After Cities Church Mob Arrest
Canadian PM Carney Just Announced a Plan to Make Canadian Inflation Worse
Faith Over Flash
'The President’s Plan Is Working,' Scott Bessent Predicts a Booming Economy in 2026
Tipsheet

The CDC Director Just Gave Us an Updated Vaccine Timeline

AP Photo/Alex Brandon

We've brought you a lot of exciting vaccine news these past few weeks. And there's more of it on Tuesday. Center for Disease Control Director Robert Redfield said Americans should expect a vaccine to be rolled out very, very soon. He predicted the second week of December.

Advertisement

The next question then is, who will be receiving the first doses. He answered that too.

In an interview with Fox News anchor Dana Perino, Redfield shared that the first groups to get the vaccine will probably be "nursing home residents and then some combination of health care providers and individuals at high risk for a poor outcome."

"I do think we'll have about 40 million doses of vaccine before the end of the...year," Redfield continued. "That's enough to vaccinate 20 million people. But then it will continue through January and February and hopefully by March we'll start to see vaccine available for the general public."

Advertisement

Pfizer, who vaccine its been developing with BioNTech has produced a 95 percent efficacy rate, requested an emergency authorization from the FDA. A second vaccine candidate being produced by Moderna isn't too far behind, reporting a 94 percent effectiveness. And then a third, developed by AstraZeneca, is up to 90 percent effective.

The FDA has reportedly scheduled a meeting for Dec. 10 with its Vaccines and Related Biological Products Advisory Committee to discuss Pfizer's request.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement